Subhani's team focused at results from six studies conducted before August of this year, including two "gold standard" clinical trials comprising a total of more than 88,000 people, about 44% of who were taking a GLP-1 medication
Fatemi I, Khaluoi A, Kaeidi A, Shamsizadeh A, Heydari S
(24) Additionally, a narrative review by Herrou et al
The mean age of the included participants was 48.8 years, and they had a mean BMI of 40.9 kg/m2
[3] Dosing of hydroxocobalamin should be individualized based on the severity of vitamin B deficiency and clinical response
If the provider says labs are optional, consider whether that level of medical oversight meets your comfort threshold